During the past decade, Oregon Health and Science University conducted 1252 clinical trials. In the 10-year time frame, 1252 clinical trials started and 713 clinical trials were completed, i.e. on average, 56.9% percent of trials that started reached the finish line to date. In the past 5 years, 530 clinical trials started and 431 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon Health and Science University" #1 sponsor was "Oregon Health and Science University" with 403 trials, followed by "National Cancer Institute (NCI)" with 128 trials sponsored, "Children's Oncology Group" with 83 trials sponsored, "Novartis Pharmaceuticals" with 46 trials sponsored and "Bristol-Myers Squibb" with 46 trials sponsored. Other sponsors include 1585 different institutions and companies that sponsored additional 691 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon Health and Science University" #1 collaborator was "National Cancer Institute (NCI)" with 188 trials as a collaborator, "Oregon Health and Science University" with 98 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 72 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 40 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 39 trials as a collaborator. Other collaborators include 1731 different institutions and companies that were collaborators in the rest 765 trials.

According to Clinical.Site data, the most researched conditions in "Oregon Health and Science University" are "Cystic Fibrosis" (44 trials), "Multiple Myeloma" (31 trials), "Acute Myeloid Leukemia" (30 trials), "Contraception" (30 trials) and "Recurrent Neuroblastoma" (29 trials). Many other conditions were trialed in "Oregon Health and Science University" in a lesser frequency.

Most popular intervention types in "Oregon Health and Science University" are "Drug" (1407 trials), "Other" (394 trials), "Biological" (247 trials), "Device" (244 trials) and "Procedure" (193 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (265 trials), "Laboratory Biomarker Analysis" (112 trials), "Cyclophosphamide" (63 trials), "Quality-of-Life Assessment" (55 trials) and "Methotrexate" (46 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Health and Science University" are 2038 trials for "All" genders, 180 trials for "Female" genders and 72 trials for "Male" genders.

Currently, there are 747 active trials in "Oregon Health and Science University". 6 are not yet recruiting, 380 are recruiting, 338 are Active, not recruiting, and 23 are Enrolling by invitation. In total, there were 1199 completed trials in Oregon Health and Science University, 13 suspended trials, and 209 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Health and Science University, 291 "Phase 1" clinical trials were conducted, 667 "Phase 2" clinical trials and 627 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 118 trials, and there were also 382 trials that are defined as “Not Applicable".

Oregon Health and Science University has several departments that took part in Clinical trials: "Doernbecher Children's Hospital" - 88 trials, "OHSU Knight Cancer Institute" - 421 trials, "OHSU Research Pharmacy Services" - 7 trials, "Oregon Health and Science University Department of Neurology" - 6 trials, "Oregon Health & Sciences Univ. Internal Medicine (L-475) CRS" - 6 trials, "Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center" - 5 trials, "OHSU School of Nursing" - 5 trials, "Oregon Health & Science University Department of Dermatology" - 5 trials, "Sleep and Mood Disorders Lab, Oregon Health & Science University" - 4 trials, "Oregon Health & Science Uni ; Dept of Pediatrics" - 3 trials, "Oregon Stroke Center" - 3 trials, "OHSU Center for Hematologic Malignancies" - 3 trials, "Oregon Health & Science Univ. - Dept. of Peds., Div. of Infectious Disease" - 2 trials, "Covance Clinical Research Unit - Dr. Andrew Ahmann" - 2 trials, "OHSU Diabetes Center Research Oregon Health & Science University" - 2 trials, "OHSU Women's Health Research Unit" - 2 trials, "Doernbecher Neonatal Care Center at Oregon Health & Science University" - 2 trials